Scholars@Duke
Shein-Chung Chow

Shein-Chung Chow

Professor of Biostatistics & Bioinformatics
Biostatistics & Bioinformatics, Division of Biostatistics
sheinchung.chow@duke.edu
Duke Box 2721, Durham, NC 27710
2424 Erwin Road Ste 1102, 11037 Hock Plaza, Durham, NC 27705

Overview

My research interest includes statistical methodology development and application in the area of biopharmaceutical/clinical statistics such as bioavailability and bioequivalence, clinical trials, bridging studies, medical devices, and translational research/medicine. Most recently, I am interested in statistical methodology development for the use of adaptive design methods in clinical trials and methodology development for assessment of biosimilarity of follow-on biologics. In addition, I am also interested in methodology development for statistical evaluation of traditional Chinese medicine (TCM) clinical trials.

Current Appointments & Affiliations

Professor of Biostatistics & Bioinformatics · 2022 - Present Biostatistics & Bioinformatics, Division of Biostatistics, Biostatistics & Bioinformatics

Recent Publications

A Hybrid Design Incorporating External Data to Evaluate Dexamethasone Intracameral Drug Delivery Suspension for Post-Cataract Surgery Inflammation.

Journal Article Clin Pharmacol Ther · December 2025 Traditional randomized controlled trials (RCTs) face increasing challenges due to lengthy recruitment and high costs. Regulators have encouraged the use of external data and real-world evidence (RWE) to improve efficiency, yet adoption in confirmatory sett ... Full text Link to item Cite

A bayesian dynamic borrowing framework for improving the efficiency of clinical trials.

Journal Article BMC Med Res Methodol · October 27, 2025 PURPOSE: To develop a Bayesian method for dynamic borrowing of information from historical clinical trials and real-world data that has the potential to improve the efficiency of clinical trials. METHODS: We propose a novel statistical metric to quantify h ... Full text Link to item Cite

Use of alternative and confirmatory data in support of rare disease drug development.

Journal Article J Biopharm Stat · October 2025 Recently, the use of alternative and confirmatory data in support of rare disease drug development has received much attention (NASEM 2024). This article attempts to provide an overview regarding the limitations and major challenges of the use of ACD that ... Full text Link to item Cite
View All Publications

Recent Grants

Targeting the B Cell Response to Treat Antibody-Mediated Rejection

ResearchStatistical Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2021 - 2028

Red blood cell ATP export and transfusion in sepsis (R01)

ResearchBiostatistician · Awarded by National Heart, Lung, and Blood Institute · 2023 - 2026

Methods to improve efficiency and robustness of clinical trials using information from real-world data with hidden bias

ResearchCo Investigator · Awarded by Food and Drug Administration · 2023 - 2026

View All Grants

Education, Training & Certifications

University of Wisconsin, Madison · 1985 Ph.D.